Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -6.75% is 110% below its 5-year average of -3.21%, near the high end of its 5-year range (-199.36%–58.46%).
As of the fiscal period ended Friday, July 31, 2026. 232.70% below its 12-month average of 5.09%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-07-31): -6.75%.
RETURN ON INVESTED CAPITAL (ROIC)
-6.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
5.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-38.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-3.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-45.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-90.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-92.92%
CURRENT VS TTM AVG
-232.70%
CURRENT VS 3Y AVG
+82.42%
CURRENT VS 5Y AVG
-110.29%
CURRENT VS 10Y AVG
+85.18%
CURRENT VS 15Y AVG
+92.57%
CURRENT VS 20Y AVG
+92.73%
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
+78.64%
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$69.33M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
5.09%
3Y Avg
-38.41%
5Y Avg
-3.21%
Market Cap
$68.78M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$70.09M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$68.43M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$68.12M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$65.81M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$65.12M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$74.00M
Return on Invested Capital (ROIC)
-159.24%
TTM Avg
-170.07%
3Y Avg
-147.54%
5Y Avg
-112.39%
Market Cap
$64.06M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $69.33M | -6.75% | 5.09% | -38.41% | -3.21% |
| PDS Biotechnology Corporation (PDSB)vs › | $68.78M | -3699.99% | -104.88% | -89.50% | -74.29% |
| iBio, Inc. (IBIO)vs › | $70.09M | -40.22% | -72.23% | -74.75% | -58.95% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.43M | -10.85% | -101.00% | -120.85% | -96.47% |
| Heron Therapeutics, Inc. (HRTX)vs › | $68.12M | -6.79% | -4.87% | -47.70% | -62.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.81M | N/A | -86.10% | -83.22% | -74.34% |
| Cingulate Inc. (CING)vs › | $65.12M | -83.74% | -153.15% | -164.21% | -165.99% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.00M | -159.24% | -170.07% | -147.54% | -112.39% |
| Alps Group Inc (ALPS)vs › | $64.06M | N/A | -165.22% | -160.52% | -107.11% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.95M | -52.40% | -44.92% | -44.92% | -44.02% |
ROIC
-6.8%
ROE
-29.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-07-31 | -6.75% |
| 2026-04-30 | -13.15% |
| 2026-01-31 | -23.71% |
| 2025-10-31 | 30.71% |
| 2025-07-31 | 38.35% |
| 2025-04-30 | 57.07% |
| 2025-01-31 | 58.46% |
| 2024-10-31 | -12.34% |
| 2024-07-31 | -60.22% |
| 2024-04-30 | -160.20% |
| 2024-01-31 | -199.36% |
| 2023-10-31 | -129.17% |
| 2023-07-31 | -79.00% |
| 2023-04-30 | -41.79% |
| 2023-01-31 | -19.84% |
| 2022-10-31 | 1.00% |
| 2022-07-31 | 2.56% |
| 2022-04-30 | 3.19% |
| 2022-01-31 | 2.34% |
| 2021-10-31 | 3.40% |
| 2021-07-31 | 1.91% |
| 2021-04-30 | 3.16% |
| 2021-01-31 | -6.49% |
| 2020-10-31 | -11.13% |
| 2020-07-31 | -9.92% |
| 2020-04-30 | -21.33% |
| 2020-01-31 | -0.09% |
| 2019-10-31 | -14.21% |
| 2019-07-31 | -15.19% |
| 2019-04-30 | 4.58% |
| 2019-01-31 | -6.64% |
| 2018-10-31 | 2.15% |
| 2018-07-31 | -16.93% |
| 2018-04-30 | -227.35% |
| 2018-01-31 | -333.16% |
| 2017-10-31 | -639.86% |
| 2017-07-31 | -1038.56% |
| 2017-04-30 | -1155.52% |
| 2017-01-31 | -303.00% |
| 2016-10-31 | -228.69% |
| 2016-07-31 | -288.31% |
| 2016-04-30 | -2189.38% |
| 2016-01-31 | -407.01% |
| 2015-10-31 | -259.74% |
| 2015-07-31 | -203.42% |
| 2015-04-30 | -160.20% |
| 2014-07-31 | -401.57% |
| 2014-04-30 | -120.07% |
| 2014-01-31 | -87.04% |
| 2013-10-31 | -71.52% |
| 2013-07-31 | -63.43% |
| 2013-04-30 | -70.98% |
| 2013-01-31 | -66.20% |
| 2012-10-31 | -608.33% |
| 2012-07-31 | -325.73% |
| 2012-04-30 | -263.62% |
| 2012-01-31 | -172.08% |
| 2011-10-31 | -128.56% |
| 2011-07-31 | -85.98% |
| 2011-04-30 | -57.21% |
| 2011-01-31 | -134.67% |
| 2010-10-31 | -206.00% |
| 2010-07-31 | -185.11% |
| 2010-04-30 | -158.96% |
| 2010-01-31 | -178.87% |
| 2009-10-31 | -680.64% |
| 2009-07-31 | -381.42% |
| 2009-04-30 | -116.57% |
| 2009-01-31 | -48.90% |
| 2008-10-31 | -7.39% |
| 2008-07-31 | -4.16% |
| 2008-04-30 | 0.18% |
| 2008-01-31 | 23.97% |
| 2007-10-31 | -33.95% |
| 2007-07-31 | -16.00% |
